These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29483100)

  • 1. Coagulation factor XII in thrombosis and inflammation.
    Maas C; Renné T
    Blood; 2018 Apr; 131(17):1903-1909. PubMed ID: 29483100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo activation and functions of the protease factor XII.
    Björkqvist J; Nickel KF; Stavrou E; Renné T
    Thromb Haemost; 2014 Nov; 112(5):868-75. PubMed ID: 25187064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII as a Therapeutic Target in Thromboembolic and Inflammatory Diseases.
    Nickel KF; Long AT; Fuchs TA; Butler LM; Renné T
    Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):13-20. PubMed ID: 27834692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact system revisited: an interface between inflammation, coagulation, and innate immunity.
    Long AT; Kenne E; Jung R; Fuchs TA; Renné T
    J Thromb Haemost; 2016 Mar; 14(3):427-37. PubMed ID: 26707513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The procoagulant and proinflammatory plasma contact system.
    Renné T
    Semin Immunopathol; 2012 Jan; 34(1):31-41. PubMed ID: 21858560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The polyphosphate/factor XII pathway in cancer-associated thrombosis: novel perspectives for safe anticoagulation in patients with malignancies.
    Nickel KF; Labberton L; Long AT; Langer F; Fuchs TA; Stavrou EX; Butler LM; Renné T
    Thromb Res; 2016 May; 141 Suppl 2():S4-7. PubMed ID: 27207422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection.
    Labberton L; Kenne E; Long AT; Nickel KF; Di Gennaro A; Rigg RA; Hernandez JS; Butler L; Maas C; Stavrou EX; Renné T
    Nat Commun; 2016 Sep; 7():12616. PubMed ID: 27596064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo.
    Müller F; Mutch NJ; Schenk WA; Smith SA; Esterl L; Spronk HM; Schmidbauer S; Gahl WA; Morrissey JH; Renné T
    Cell; 2009 Dec; 139(6):1143-56. PubMed ID: 20005807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
    Labberton L; Kenne E; Renné T
    Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel roles for factor XII-driven plasma contact activation system.
    Müller F; Renné T
    Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
    Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
    Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.
    Nickel KF; Ronquist G; Langer F; Labberton L; Fuchs TA; Bokemeyer C; Sauter G; Graefen M; Mackman N; Stavrou EX; Ronquist G; Renné T
    Blood; 2015 Sep; 126(11):1379-89. PubMed ID: 26153520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contact system in liver injury.
    Rangaswamy C; Mailer RK; Englert H; Konrath S; Renné T
    Semin Immunopathol; 2021 Aug; 43(4):507-517. PubMed ID: 34125270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor XII(a) inhibitors: a review of the patent literature.
    Kalinin DV
    Expert Opin Ther Pat; 2021 Dec; 31(12):1155-1176. PubMed ID: 34142629
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations.
    de Maat S; Björkqvist J; Suffritti C; Wiesenekker CP; Nagtegaal W; Koekman A; van Dooremalen S; Pasterkamp G; de Groot PG; Cicardi M; Renné T; Maas C
    J Allergy Clin Immunol; 2016 Nov; 138(5):1414-1423.e9. PubMed ID: 27130860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.